Validation of novel eligibility criteria by integrating ALBI grade and progression pattern for sorafenib-failed hepatocellular carcinoma

作者：P.-C. Lee, Y.-T. Chen, Yu Chao, The-Ia Huo, Chun Li, Chaojiang Su, M.-H. Lee, M.-C. Hou, F.-Y. Lee, Han-Chieh Lin, Yi‐Hsiang Huang · 发表于：Journal of Hepatology · 年份：2017 · DOI：10.1016/s0168-8278(17)31680-x · 被引用次数：1 · 研究领域：Hepatocellular Carcinoma Treatment and Prognosis、Liver Disease Diagnosis and Treatment、Hepatitis C virus research